Cargando…

Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine

OBJECTIVES: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. CASE REPORT: The patient is a 33yo male who experienced an episo...

Descripción completa

Detalles Bibliográficos
Autores principales: Finsterer, Josef, Nics, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651552/
https://www.ncbi.nlm.nih.gov/pubmed/34901793
http://dx.doi.org/10.1016/j.hest.2021.12.001
_version_ 1784611421659594752
author Finsterer, Josef
Nics, Sebastian
author_facet Finsterer, Josef
Nics, Sebastian
author_sort Finsterer, Josef
collection PubMed
description OBJECTIVES: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. CASE REPORT: The patient is a 33yo male who experienced an episode of sudden onset focal, stabbing headache in the left temporal region for about 4 h. Three days later a similar episode occurred accompanied by a focal seizure. Twenty days before he had received the second dose of the Pfizer vaccine. Clinical exam was normal but MRI of the brain revealed a VST of the left transverse and sigmoid sinuses. Anticoagulation with low molecular weight heparin followed by dabigatran resulted in complete recovery. CONCLUSIONS: This case shows that also the second dose of the Pfizer vaccine can be followed by a VST. Currently, there are more arguments in favour of a causal relation between the vaccination and the VST than against it.
format Online
Article
Text
id pubmed-8651552
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86515522021-12-08 Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine Finsterer, Josef Nics, Sebastian Brain Hemorrhages Case Report OBJECTIVES: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. CASE REPORT: The patient is a 33yo male who experienced an episode of sudden onset focal, stabbing headache in the left temporal region for about 4 h. Three days later a similar episode occurred accompanied by a focal seizure. Twenty days before he had received the second dose of the Pfizer vaccine. Clinical exam was normal but MRI of the brain revealed a VST of the left transverse and sigmoid sinuses. Anticoagulation with low molecular weight heparin followed by dabigatran resulted in complete recovery. CONCLUSIONS: This case shows that also the second dose of the Pfizer vaccine can be followed by a VST. Currently, there are more arguments in favour of a causal relation between the vaccination and the VST than against it. International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2022-03 2021-12-08 /pmc/articles/PMC8651552/ /pubmed/34901793 http://dx.doi.org/10.1016/j.hest.2021.12.001 Text en © 2021 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Finsterer, Josef
Nics, Sebastian
Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
title Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
title_full Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
title_fullStr Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
title_full_unstemmed Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
title_short Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
title_sort venous sinus thrombosis after the second jab of an mrna-based sars-cov-2 vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651552/
https://www.ncbi.nlm.nih.gov/pubmed/34901793
http://dx.doi.org/10.1016/j.hest.2021.12.001
work_keys_str_mv AT finstererjosef venoussinusthrombosisafterthesecondjabofanmrnabasedsarscov2vaccine
AT nicssebastian venoussinusthrombosisafterthesecondjabofanmrnabasedsarscov2vaccine